These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32417907)

  • 1. High-molecular-weight von Willebrand Factor multimer ratio differentiates true-severe from pseudo-severe classical low-flow, low-gradient aortic stenosis.
    Kellermair J; Saeed S; Ott HW; Kammler J; Blessberger H; Suppan M; Grund M; Kiblboeck D; Urheim S; Chambers JB; Steinwender C
    Eur Heart J Cardiovasc Imaging; 2020 Oct; 21(10):1123-1130. PubMed ID: 32417907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of true-severe classical low-flow low-gradient aortic stenosis at resting echocardiography.
    Kellermair J; Saeed S; Chambers JB; Kammler J; Blessberger H; Grund M; Kiblboeck D; Lambert T; Steinwender C
    Int J Cardiol; 2021 Jul; 335():93-97. PubMed ID: 33662487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis.
    Kellermair J; Ott HW; Spannagl M; Tomasits J; Kammler J; Blessberger H; Reiter C; Steinwender C
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):496-501. PubMed ID: 29202604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).
    Blackshear JL; Wysokinska EM; Safford RE; Thomas CS; Stark ME; Shapiro BP; Ung S; Johns GS; Chen D
    Am J Cardiol; 2013 Feb; 111(3):374-81. PubMed ID: 23168287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
    Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
    Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
    Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
    J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis.
    Annabi MS; Touboul E; Dahou A; Burwash IG; Bergler-Klein J; Enriquez-Sarano M; Orwat S; Baumgartner H; Mascherbauer J; Mundigler G; Cavalcante JL; Larose É; Pibarot P; Clavel MA
    J Am Coll Cardiol; 2018 Feb; 71(5):475-485. PubMed ID: 29406851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
    Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
    Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
    Casonato A; Galletta E; Cella G; Barbon G; Daidone V
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
    Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
    Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease.
    Boender J; Atiq F; Cnossen MH; van der Bom JG; Fijnvandraat K; de Meris J; de Maat MPM; van Galen KPM; Laros-van Gorkom BAP; Meijer K; Eikenboom J; Leebeek FWG
    Hemasphere; 2021 Mar; 5(3):e542. PubMed ID: 33623884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction.
    Liu D; Hu K; Liebner E; Weidemann F; Herrmann S; Ertl G; Frantz S; Nordbeck P
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1877-1887. PubMed ID: 30039338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
    Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
    Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Strategies for Evaluating Low-Flow, Low-Gradient Aortic Stenosis with Reduced and Preserved Left Ventricular Ejection Fraction.
    Alluri K; Carabello BA; Nekkanti R
    Curr Cardiol Rep; 2019 Jul; 21(9):94. PubMed ID: 31352636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic role of "acceleration time" measurement in patients with classical low flow low gradient aortic stenosis with reduced left ventricular ejection fraction.
    Sancar KM; Guler GB; Tanboga HI; Cansever AT; Demir AR; Guler A; Tekin M; Uygur B; Birant A; Avci Y; Guler E; Erturk M
    Int J Cardiovasc Imaging; 2023 Mar; 39(3):481-489. PubMed ID: 36394680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.
    Favaloro EJ; Oliver S; Mohammed S; Vong R
    Haemophilia; 2020 May; 26(3):503-512. PubMed ID: 32159272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Dobutamine Stress Echocardiography to the Diagnosis and Prognosis of Low-Flow/Low-Gradient Aortic Stenosis.
    Aguiar Rosa S; Moura Branco L; Galrinho A; Portugal G; Abreu J; Cacela D; Fragata J; Cruz Ferreira R
    J Heart Valve Dis; 2016 Mar; 25(2):130-138. PubMed ID: 27989054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.